Small cap stocks are retreating. So are biotechnology names. Yet this combo could be an attractive invitation to examine with the Defiance Nasdaq Junior Biotechnology ETF (IBBJ). IBBJ, which debuted last year, tracks the Nasdaq Junior Biotechnology Index (NBIJR), which is home to nearly 180 stocks. The benchmark caps components’ market value at $5 billion at […]
The post Why Small Cap Biotech ETFs Are Still Brilliant Bets appeared first on ETF Trends.